region due to maternal morbidity, malnutrition, and a heavy burden of infectious diseases such as malaria [22, 49]. Generally, little attention has been given to the clinical safety component of the blood thereby minimizing the risks involved with blood transfusion practices and improving the blood supply system and appropriate clinical use of blood within the health care facilities. Although there are limited studies that indicate the current approach of blood transfusion practices and the need assessment for blood components therapy in Ethiopia, this study aimed at identifying the demographic characteristics of recipients, blood type distribution, and the practice of appropriate clinical utilization patterns of blood and blood products in the study area. A facility-based cross-sectional study was conducted in Jimma medical center (JMC), Jimma University, southwest Ethiopia. Blood transfusion requests of 425 patients from different clinical departments were included consecutively. The study was conducted from February 1 to June 30, 2018. Any blood-prescribing physician and patient for whom a blood transfusion intervention was clinically indicated and blood or blood component requested during the study period were included voluntarily. Currently, the medical center was developing local blood and blood product transfusion SOP, maximum surgical blood ordering schedule (MSBOS), and transfusion guideline through the newly established transfusion committee. Data collection and analysis Socio-demographic and blood transfusion-related data were collected using a checklist developed after reviewing different works of literature. The checklist included age, gender, clinical wards, pre-transfusion hemoglobin level, blood group of patient and unit, transfusion indication, number of units requested, blood components indicated and administered, prescribing physician, ethical issues/consent/ for blood transfusion. The data were extracted from manually completed blood bank request papers and followed prospectively to the wards for transfusion completion by a trained medical laboratory technologist. Completeness and consistency check was done before data were entered, coded, organized, and analyzed by SPSS® software version 23.0 (Armonk, NY: IBM Corps.); and C/T ratios, TI and TP% were calculated by Microsoft® excel (Microsoft® office 2010, Microsoft Corporation, USA). Statistics Appropriate descriptive and frequency summaries, percentages, and ratios were carried out to describe the study variables. Results of the study were presented using narration statements, .Appropriateness of blood transfusion was decided based on the algorithm-based criteria set below [50–52]. Adult medicine: by considering blood transfusion in the case of hypoxia Surgery: ≥10 g/dl no need of transfusion, 7–8 g/dl in a well-compensated healthy individual not necessary, but if the surgical patient is with uncompensated or inadequately compensated anemia, major surgery with anticipated significant blood loss with the procedure transfuse packed RBC. The following mathematical steps were used for calculations of C/T ratio, TP%, TI, and I:T: [34, 37, 53]. Cross-match to transfusion ratio (C/T ratio): number of units cross-matched/number of units transfused. A ratio of ≤2.5 is considered indicative of efficient blood use. Transfusion probability (TP %): number of patients transfused over the number of patients cross-matched by 100. A value of ≥30% considered being significant blood usage. Transfusion index (TI): number of units transfused/ number of patients cross-matched. A value of ≥0.5 is considered significant blood utilization. Issue to transfusion index (I:T): number of blood issued to patients over the actual number of units transfused to patients. Quality assurance The checklist was prepared in the English language. Orientation was given to all data collectors regarding the procedures to be followed during the data collection, then collected data were reviewed and checked for completeness and consistency daily by the PI, and two supervisors. Ethics approval and consent to participate Ethical clearance was obtained from the Ethical Review Board of Institute of Health, Jimma University. Permission from the Medical director of JMC and written informed consent from each participant was taken prior to any data collection and follow up. Written informed consent was also taken from parents and legal guardians in cases of minors for the use of their clinical and demographic data for this study. Transfusion was solely initiated by authorized physician as part of regular patient management, where all transfusion practices were followed after that till completion, and no transfusion was initiated by investigators. Confidentiality was maintained at all levels of the study and all the information obtained was used for this study only. Results Demographic and clinical data A total of 425 blood transfusion